Literature DB >> 1757543

Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis.

J E Dawson1, B E Anderson, D B Fishbein, J L Sanchez, C S Goldsmith, K H Wilson, C W Duntley.   

Abstract

A new disease was recognized in the United States in 1986. The etiologic agent, although not previously isolated from a human, appeared to be serologically related to Ehrlichia canis, a canine leukotropic rickettsia. We obtained blood specimens from 27 febrile patients with a history of tick exposure. Leukocytes from 24 patients not treated with tetracycline were placed onto a monolayer of DH82 cells. We performed indirect immunofluorescence on sera from all 27 febrile patients as well as sera from 12 patients with previously diagnosed ehrlichiosis. Intractoplasmic inclusions were first observed in culture 35 days after the addition of infected blood from one patient. Partial sequencing of the rRNAs from the human isolate and E. canis indicated that they are 98.7% related. Positive indirect immunofluorescence reactions to the human isolate were obtained for all 12 previously diagnosed patients and for 33% of the 27 febrile patients. Two patients were seropositive for the human isolate but not for E. canis. No sera were positive for E. canis and negative for the human isolate. We report the isolation of a previously unrecognized Ehrlichia sp. that appears to be the etiologic agent of human ehrlichiosis. Serologic data (range of antibody titers, 256 to 32,768) in combination with rRNA sequencing indicated that the newly isolated Ehrlichia sp. is similar, but not identical, to E. canis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757543      PMCID: PMC270425          DOI: 10.1128/jcm.29.12.2741-2745.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens.

Authors:  D A Relman; J S Loutit; T M Schmidt; S Falkow; L S Tompkins
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

2.  Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction.

Authors:  K H Wilson; R B Blitchington; R C Greene
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

3.  16S ribosomal DNA amplification for phylogenetic study.

Authors:  W G Weisburg; S M Barns; D A Pelletier; D J Lane
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

4.  Human infection with Ehrlichia canis, a leukocytic rickettsia.

Authors:  K Maeda; N Markowitz; R C Hawley; M Ristic; D Cox; J E McDade
Journal:  N Engl J Med       Date:  1987-04-02       Impact factor: 91.245

5.  Simultaneous ehrlichiosis and Lyme disease.

Authors:  L L Barton; J E Dawson; G W Letson; A Luisiri; A J Scalzo
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

6.  An outbreak of ehrlichiosis in members of an Army Reserve unit exposed to ticks.

Authors:  L R Petersen; L A Sawyer; D B Fishbein; P W Kelley; R J Thomas; L A Magnarelli; M Redus; J E Dawson
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

7.  Detection of Rickettsia rickettsii DNA in clinical specimens by using polymerase chain reaction technology.

Authors:  T Tzianabos; B E Anderson; J E McDade
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

8.  Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988.

Authors:  T R Eng; J R Harkess; D B Fishbein; J E Dawson; C N Greene; M A Redus; F T Satalowich
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

9.  Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients.

Authors:  D B Fishbein; A Kemp; J E Dawson; N R Greene; M A Redus; D H Fields
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

10.  Unexplained febrile illnesses after exposure to ticks. Infection with an Ehrlichia?

Authors:  D B Fishbein; L A Sawyer; C J Holland; E B Hayes; W Okoroanyanwu; D Williams; K Sikes; M Ristic; J E McDade
Journal:  JAMA       Date:  1987-06-12       Impact factor: 56.272

View more
  131 in total

1.  Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.

Authors:  R E Barnewall; N Ohashi; Y Rikihisa
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors.

Authors:  Koshiro Miura; Junji Matsuo; M Akhlakur Rahman; Yumi Kumagai; Xin Li; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

3.  Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State.

Authors:  S J Wong; G S Brady; J S Dumler
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  Ehrlichiosis in a visitor to Virginia.

Authors:  R W Armstrong
Journal:  West J Med       Date:  1992-08

5.  Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.

Authors:  S R Telford; J E Dawson; P Katavolos; C K Warner; C P Kolbert; D H Persing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

6.  Survival strategy of obligately intracellular Ehrlichia chaffeensis: novel modulation of immune response and host cell cycles.

Authors:  Jian-zhi Zhang; Mala Sinha; Bruce A Luxon; Xue-jie Yu
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice.

Authors:  Roman R Ganta; Chuanmin Cheng; Melinda J Wilkerson; Stephen K Chapes
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Attenuated Mutants of Ehrlichia chaffeensis Induce Protection against Wild-Type Infection Challenge in the Reservoir Host and in an Incidental Host.

Authors:  Arathy D S Nair; Chuanmin Cheng; Deborah C Jaworski; Suhasini Ganta; Michael W Sanderson; Roman R Ganta
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

9.  Four VirB6 paralogs and VirB9 are expressed and interact in Ehrlichia chaffeensis-containing vacuoles.

Authors:  Weichao Bao; Yumi Kumagai; Hua Niu; Mamoru Yamaguchi; Koshiro Miura; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2008-10-24       Impact factor: 3.490

10.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.